Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Oct 15, 2026; 18(10): 121827
Published online Oct 15, 2026. doi: 10.4251/wjgo.121827
Published online Oct 15, 2026. doi: 10.4251/wjgo.121827
Figure 3 PARVA knockdown suppressed the proliferation, migration, and invasion of gastric cancer cells.
A: Western blot analysis of PARVA knockdown efficiency in AGS and HGC27 cells, with densitometric analysis; B: Colony formation assays with quantification of colony numbers; C: EdU assays with quantification of EdU-positive cells; D: Transwell migration and invasion assays with quantification; E: Wound-healing assays with quantification of wound closure. When followed by a numeral, the comparison refers to the corresponding control within the indicated subgroup. aP < 0.01; bP < 0.001; 1Comparison within the migration subgroup; 2Comparison within the invasion subgroup; 3Comparison within the 0 hours subgroup; 4Comparison within the 48 hours subgroup. NS: Not significant; NC: Negative control.
- Citation: Lu X, Li J, Wang ML, Wang HZ, Li YX. PARVA promotes gastric cancer progression through FBXO15-related PI3K/AKT signaling. World J Gastrointest Oncol 2026; 18(10): 121827
- URL: https://www.wjgnet.com/1948-5204/full/v18/i10/121827.htm
- DOI: https://dx.doi.org/10.4251/wjgo.121827